Falchi, Lorenzo, Jessica M Baron, Carrie Anne Orlikowski, and Alessandra Ferrajoli. “BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”. Mediterranean Journal of Hematology and Infectious Diseases 80 (February 10, 2016): e2016011. Accessed July 5, 2020. http://mjhid.org/index.php/mjhid/article/view/2016.011.